![Andrew Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Parker
Directeur Général chez
ArisGen SA
Profil
Andrew Parker is currently the Chief Executive Officer of ArisGen SA and the Chief Executive Officer & Member-Supervisory Board of Step Pharma SAS. Previously, he worked as the General Partner & Scientific Director of Eclosion2 SA, Independent Director of GeNeuro SA (Switzerland), Scientific Director & General Partner of Eclosion2 & Cie Scpc, Principal at AstraZeneca PLC and Beerse Betonhandel, Vice President & Head-Exploratory Projects at Shire Plc, Chief Science Officer & Executive Vice President at Zealand Pharma A, Principal at Janssen Pharmaceutica NV, and Vice President-Pre Clinical Research at Opsona Therapeutics Ltd. Dr. Parker holds an MBA from Warwick Business School and a doctorate from The National Institute For Medical Research.
Postes actifs de Andrew Parker
| Sociétés | Poste | Début |
|---|---|---|
ArisGen SA
 ArisGen SA Pharmaceuticals: MajorHealth Technology Manufactures novel products | Directeur Général | - |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Directeur Général | 05/09/2019 |
Anciens postes connus de Andrew Parker
| Sociétés | Poste | Fin |
|---|---|---|
| ZEALAND PHARMA A/S | Directeur Technique/Scientifique/R&D | 31/08/2019 |
Eclosion2 SA
 Eclosion2 SA Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | - |
Eclosion2 & Cie Scpc | Corporate Officer/Principal | - |
| SHIRE | Corporate Officer/Principal | - |
| GENEURO SA | Directeur/Membre du Conseil | - |
Formation de Andrew Parker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Warwick Business School
 Warwick Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Beerse Betonhandel
 Beerse Betonhandel Regional BanksFinance Functions Related To Depository Banking Not Elsewhere Classified | Finance |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
The National Institute For Medical Research
 The National Institute For Medical Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Health Technology |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Provides financial services | Finance |
ArisGen SA
ArisGen SA Pharmaceuticals: MajorHealth Technology Manufactures novel products | Health Technology |
GeNeuro SA (Switzerland)
 GeNeuro SA (Switzerland) BiotechnologyHealth Technology Engages in the research and development of pharmaceutical products to treat neurological diseases | Health Technology |
Eclosion2 & Cie Scpc | |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
